Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Victor Moreno

Director

Hospital Universitario Fundación Jiménez Díaz

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Collaborators (23)

Han Sang Kim

Associate Professor

Yonsei Cancer Center

SOUTH KOREA

View details

Kok Haw Jonathan Lim

Clinical Senior Lecturer in Cancer Biology

The University of Manchester

UNITED KINGDOM

View details

Thomas Powles

Professor of Genitourinary Oncology

Queen Mary University of London

UNITED KINGDOM

View details

Henry Kao

Group Head, Biomarker Sciences

SWITZERLAND

View details

Hong Jae Chon

Associate Professor

CHA Bundang Medical Center

SOUTH KOREA

View details

TAEK WON KANG

Professor

Chonnam National University Medical School

SOUTH KOREA

View details

Martin D. Berger

Department of Medical Oncology, Inselspital, Bern University Hospital

SWITZERLAND

View details

Rosalyn Juergens

CANADA

View details

Tae Min Kim

Seoul National University Hospital

SOUTH KOREA

View details

Garcia-Foncillas J

Full Professor

Universidad Autónoma de Madrid

SPAIN

View details

Maria Reig

Director

University of Barcelona

SPAIN

View details

Rebecca S. Kristeleit

University of Arizona College of Medicine

UNITED STATES

View details

Hans Prenen

Antwerp University Hospital

BELGIUM

View details

yvette drew

Associate Professor

The University of British Columbia

CANADA

View details

Do Young Kim

Professor

Yonsei University College of Medicine

SOUTH KOREA

View details

Yohann Loriot

Institut Gustave Roussy

FRANCE

View details

Susana Banerjee

Professor in Women's Cancers (Systemic Therapy and Clinical Trials)

Institute of Cancer Research

UNITED KINGDOM

View details

Darren Wan-Teck Lim

Assoc Prof

SINGAPORE

View details

Elena Garralda

Director

SPAIN

View details

Jeong Heo

Professor

Pusan National University

SOUTH KOREA

View details

Kristoffer Rohrberg

Ass. Professor

Faculty of Health and Medical Sciences, University of Copenhagen

DENMARK

View details

Rozita Abdul Malik

CLINICAL ONCOLOGIST/ LECTURER

University of Malaya

MALAYSIA

View details

Eric Van Cutsem

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Victor Moreno

Research Interests

Explore related searches

Articles (20)

A First-in-Human Phase I Clinical Trial Evaluating Clinical Activity and Proof of Mechanism of Tobemstomig, a PD-1–LAG-3 Bispecific Antibody, in Patients with CPI-Experienced Melanoma

Abstract 1008: Effect of the KRAS G12C inhibitor MK-1084 on circulating tumor DNA levels in participants with KRAS G12-mutated tumors

A phase 1b study to evaluate the safety, tolerability and preliminary efficacy of a heterologous prime boost vaccination (ATP150/ATP152/ATP162, VSV-GP154) and ezabenlimab (BI 754091) in patients with pancreatic ductal adenocarcinoma.

A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma

Advances in cell therapy for solid tumours: European perspective and future directions

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer

Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study

HER2-directed TAC T cells in solid tumors: a step forward, but not yet a therapeutic leap

Landscape of T-cell engagers in solid tumors

A phase 1/2 trial investigating REGN5668, a MUC16×CD28 costimulatory bispecific antibody, in combination with other targeted therapies in patients with recurrent ovarian or endometrial cancer: trial in progress update

Baseline biomarker analysis and clinical outcomes of the PD-1/TGFβR2 bispecific antibody INCA33890 in patients with non-MSI-H metastatic colorectal cancer (mCRC)

Clinical and genomic characterization of biliary tract tumors (BTT) with ARID1A mutations: A case-control study

Efficacy and safety of mevrometostat (M) in combination with enzalutamide (E) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Data from a phase 1 study.

Establishment and characterization of a panel of EGFR-mutant lung XPDX models representing naïve, chemotherapy, and targeted therapy-resistant patient populations

Establishment of a translational research ecosystem: A globally networked PDX model platform to accelerate oncology drug development

FGFR3-TACC3 fusion: multi-omics and machine learning characterization across tumor types

Genetic variation and regulation of MICA alters natural killer cell-mediated immunosurveillance in early-onset colorectal cancer

Gut microbiota perturbations in response to SARS-CoV-2 and survival outcomes in patients with cancer.

Derivation and External Validation of Objective Performance Status Among Patients With Metastatic Cancer

Collaborators (23)

Han Sang Kim

Kok Haw Jonathan Lim

Thomas Powles

Henry Kao

Hong Jae Chon

TAEK WON KANG

Martin D. Berger

Rosalyn Juergens

Tae Min Kim

Garcia-Foncillas J

Maria Reig

Rebecca S. Kristeleit

Hans Prenen

yvette drew

Do Young Kim

Yohann Loriot

Susana Banerjee

Darren Wan-Teck Lim

Elena Garralda

Jeong Heo

Kristoffer Rohrberg

Rozita Abdul Malik

Eric Van Cutsem

Make your next move.